Announcement on Voluntary Disclosure of FDA Approval for the Clinical Trial Application for 7MW4911 Injection

About this update from Mabwell (shanghai) Bioscience Co., Ltd. Class A

Announcement on Voluntary Disclosure of FDA Approval for the Clinical Trial Application for 7MW4911 InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Mabwell (shanghai) Bioscience Co., Ltd. Class A